Daquan energy: the polysilicon sales volume in the first quarter is expected to increase by 72.33% - 76.98% year-on-year

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

Toyota Partners with Chinese battery giant CATL (宁德时代) for localized battery production in Indonesia, aiming to build ASEAN EV hub

On April 20, Toyota Motor Manufacturing Indonesia (TMMIN) and CATL (宁德时代) officially announced a strategic partnership in Jakarta to promote the localized production of Hybrid Electric Vehicle (HEV) batteries in Indonesia. The project involves a total investment of approximately 1.3 trillion IDR (approx. 76 million USD; Note: original reports of 13 trillion IDR were corrected by the Jakarta Post to 1.3 trillion IDR, primarily for production equipment).

Chinese technology enterprise Dreame (追觅科技) reports eight consecutive years of doubled revenue, leading market share in over 30 countries

On April 20, Yu Hao (俞浩), founder and CEO of Dreame Technology (追觅科技), shared his unique business philosophy in an interview. He revealed that since its founding in 2017, Dreame has achieved an average annual revenue growth of 100% for eight consecutive years. By the end of 2025, Dreame’s products reached 120 countries and regions, securing the No. 1 market share in the robotic vacuum segment across more than 30 countries, including Germany, Italy, and Singapore.

Chinese smartphone manufacturer OPPO Find X9 Ultra makes global debut, penetrating Europe’s high-end market and entering Mongolia

On April 21, OPPO officially announced that its top-tier flagship Find X9 Ultra series will be launched outside of China for the first time, reaching 26 countries and regions simultaneously. The initial rollout includes core markets such as Spain, Italy, the UK, France, Sweden, and Singapore.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.